BackHistogen Overview

Histogen Receivables

Histogen's receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
100.00% YoYΔ $-74000.00 vs prior year quarter

Peer average

Loading

Histogen Receivables History

Loading

Histogen vs. peers: Receivables Comparison

Loading

Histogen Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Histogen (HSTO) FAQ

As of the most recent data (September 2023), HSTO shows a receivables of $0. That compares with $74K in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HSTO's receivables is now $0 (was $74K) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Histogen is outperforming or lagging.

Tracking HSTO's receivables over time shows whether Histogen is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $74K in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Histogen's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.

Histogen's receivables is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.